Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
03 Agosto 2023 - 7:30PM
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that
Chairman and Chief Executive Officer Jim Green will present to
investors at the Sidoti August Virtual Investor Conference on
August 16, 2023. Joining him will be Jennifer Cote, the company’s
Chief Financial Officer and Treasurer.
The presentation will begin at 11:30 a.m. ET on Wednesday,
August 16th and can be accessed live here. The presentation will
also be archived on the Investor Relations section of the Harvard
Bioscience website for a limited period of time.
Harvard Bioscience will also host virtual one-on-one meetings
with investors on Wednesday August 16 and Thursday August 17. To
register for the presentation or to schedule a one-on-one meeting,
please visit www.sidoti.com/events.
About Harvard
Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer
and seller of technologies, products and services that enable
fundamental advances in life science applications, including
research, pharmaceutical and therapy discovery, bio-production and
preclinical testing for pharmaceutical and therapy development. Our
customers range from renowned academic institutions and government
laboratories to the world’s leading pharmaceutical, biotechnology
and contract research organizations. With operations in North
America, Europe, and China, we sell through a combination of direct
and distribution channels to customers around the world.
For more information, please visit our website
at www.harvardbioscience.com.
Investor Contact:
Harvard Bioscience, Inc. Investor
Relations (508)
893-3120 investors@harvardbioscience.com
Harvard Bioscience (NASDAQ:HBIO)
Gráfico Histórico do Ativo
De Jul 2024 até Ago 2024
Harvard Bioscience (NASDAQ:HBIO)
Gráfico Histórico do Ativo
De Ago 2023 até Ago 2024